Your browser doesn't support javascript.
loading
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer.
Keenan, Tanya E; Guerriero, Jennifer L; Barroso-Sousa, Romualdo; Li, Tianyu; O'Meara, Tess; Giobbie-Hurder, Anita; Tayob, Nabihah; Hu, Jiani; Severgnini, Mariano; Agudo, Judith; Vaz-Luis, Ines; Anderson, Leilani; Attaya, Victoria; Park, Jihye; Conway, Jake; He, Meng Xiao; Reardon, Brendan; Shannon, Erin; Wulf, Gerburg; Spring, Laura M; Jeselsohn, Rinath; Krop, Ian; Lin, Nancy U; Partridge, Ann; Winer, Eric P; Mittendorf, Elizabeth A; Liu, David; Van Allen, Eliezer M; Tolaney, Sara M.
Afiliação
  • Keenan TE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Guerriero JL; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
  • Barroso-Sousa R; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Li T; Breast Tumor Immunology Laboratory, Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • O'Meara T; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Giobbie-Hurder A; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, USA.
  • Tayob N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hu J; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Severgnini M; Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil.
  • Agudo J; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Vaz-Luis I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Anderson L; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Attaya V; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Park J; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Conway J; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • He MX; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Reardon B; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shannon E; Medical Oncology Department, INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Institut Gustave Roussy, Villejuif, France.
  • Wulf G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Spring LM; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Jeselsohn R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Krop I; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Partridge A; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mittendorf EA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
  • Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Van Allen EM; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
  • Tolaney SM; Harvard Graduate Program in Biophysics, Boston, MA, USA.
Nat Commun ; 12(1): 5563, 2021 09 21.
Article em En | MEDLINE | ID: mdl-34548479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Furanos / Cetonas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Furanos / Cetonas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article